drugset / Trial / NCT00370825

Combination Chemotherapy for the Treatment of Indian Kala-Azar

NCT00370825

Phase 2 Completed 200 enrolled Banaras Hindu University
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators are using a sequential design to combine miltefosine and AmBisome in different doses.

Timeline

Start
2006-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown 3.75 mg/kg
Subject Amphotericin B Unknown 5 mg/kg
Subject Miltefosine Small molecule Oral